Sepsis-induced myocardial dysfunction: pathophysiology and management

Area of Science:

• Cardiology
• Immunology
• Critical Care Medicine

Background:

• Sepsis involves an inappropriate immune response to pathogens, potentially leading to multiple organ failure.
• Septic cardiomyopathy, characterized by diastolic dysfunction, is a recognized complication of sepsis.
• Both pathogen-associated molecular patterns (PAMPs) and endogenous damage-associated molecular patterns (DAMPs) contribute to myocardial dysfunction in sepsis.

Purpose of the Study:

• To review the features of septic myocardial dysfunction.
• To assess the underlying mechanisms of septic cardiomyopathy.
• To outline current and potential future therapeutic strategies for septic myocardial dysfunction.

Main Methods:

• Literature review of studies on sepsis and myocardial dysfunction.
• Analysis of the roles of PAMPs and DAMPs in septic cardiomyopathy.
• Evaluation of therapeutic interventions for septic shock and its cardiac effects.

Main Results:

• Sepsis-induced myocardial dysfunction is characterized by diastolic dysfunction.
• PAMPs and DAMPs (e.g., extracellular histones, HMGB1) activate inflammatory pathways contributing to cardiac injury.
• Early infection control and appropriate fluid resuscitation are crucial, while excessive interventions may be detrimental.

Conclusions:

• Septic cardiomyopathy is a complex condition driven by immune dysregulation.
• Targeting PAMPs and DAMPs, alongside timely and judicious medical management, is essential for improving outcomes.
• Further research into novel therapeutic approaches is warranted.